Insulin Stimulates the Synthesis of Plasminogen Activator Inhibitor 1 by the Human Hepatocellular Cell Line Hep G2

Summary

Secretion of plasminogen activator inhibitor 1 (PAI-1) by cultures of human umbilical vein endothelial cells and human hepatocellular cell line Hep G2 was evaluated after insulin stimulation. The secretion of PAI-1 antigen and activity was measured in the conditioned medium and the cellular extracts after incubation of confluent cultures with 1% serum medium for 24 hours.

Insulin induced a dose dependent increase of the PAI-1 secretion by Hep G2 cell line. At 10^-8 M a two fold increase of PAI-1 antigen and activity were observed whereas a2 antiplasmin and fibrinogen were not significantly modified. No effect of insulin was observed on PAI-1 antigen and PAI activity production by human endothelial cells whereas endotoxin resulted in a two fold increase in PAI-1 secretion. In recent clinical studies we have demonstrated that the level of plasma insulin correlated with that of PAI-1. Thus we hypothesize that hepatocytes represent a physiological source of plasma PAI-1 which is modulated by plasma insulin level.

Keywords

Insulin - PAI-1 - Hepatocyte - Endothelial cell

• References

• 1 Paiainu JA, Colueei M, Collen D. Plasminogen activator inhibitor in the hlnnri of pnticnts with coronary artery disease. Dr Med J 1985; 281: 573-8
• 2 Nilsson IM, Ljungner H, Tengborn L. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator and increased concentration of plasminogen activator inhibitor. Br Med J 1985; 290: 1453-6
• 3 Juhan-Vague I, Valadier J, Alessi MC, Aillaud MF, Ansaldi J, Philip Joet C, Holvoet P, Serradimigni A, Collen D. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemostas 1987; 57: 67-72
• 4 Aillaud MF, Juhan-Vague T, Alessi MC, Marecal M, Vinson MF, Arnaud C, Vague P, Collen D. Increased PA-inhibitor levels in the postoperative period - No relationship with increased cortisol. Thromb Haemostas 1985; 54: 466-8
• 5 Hamsten A, Walldius G, Szaposi A, Blomback M, De Faire U, Dahlen G, Landou C, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2: 3-9
• 6 Loskutoff DJ, Van Mourik JA, Erickson LA, Lawrence D. Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. Proc Natl Acad Sci USA 1983; 80: 2956-60
• 7 Sprengers ED, Princen HM G, Kooistra T, Hinsberg VW M Van. Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2. J Lab Clin Med 1985; 105: 751-8
• 8 Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987; 69: 381-7
• 9 Colucci M, Paramo JA, Collen D. Generation in plasma of a fast acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest 1985; 74: 818-24
• 10 Emeis JJ, Kooistra T. Interleukin-1 and lipopolysaccharide induce a fast acting inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 1986; 163: 1260-6
• 11 Coleman PL, Barouski PL, Gelehrter TD. The dexamethasone-induced inhibitor of fibrinolytic activity in hepatoma cells. J Biol Chem 1982; 257: 4260-6
• 12 Juhan-Vague I, Vague P, Alessi MC, Badier C, Valadier J, Aillaud MF, Atlan C. Relationships between plasma insulin triglyceride, body mass index and plasminogen activator inhibitor 1. Diab Metabol 1987; 13: 331-6
• 13 Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects. Metabolism 1986; 2: 250-3
• 14 Rijken DC, Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 1981; 256: 7035-40
• 15 Declerck PJ, Alessi MC, Vestreken M, Kruithof EK O, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 (PAI-1) in biological fluids with a murine monoclonal antibody based enzyme linked immunosorbent assay. Blood 1988; 71: 220-5
• 16 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-56
• 17 Verheijen JH, Chang GT G, Kluft C. Evidence for the occurrence of a fast acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-5
• 18 Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Ann Biochem 1976; 72: 248-54
• 19 Misbin RI, Menmee TJ, Lowenslein JM. Insulin removal by isolated perfused rat liver. Am J Physiol 1976; 230: 171-7
• 20 Fieychet P. The interactions of prolnsulln with insulin receptors on the plasma meinbiane of the liver. J Clin Invest 1974; 54: 1020-31
• 21 Rosen OM. After insulin binds. Science 1987; 237: 1452-8
• 22 King GL, Buzney SM, Kahn CR, Hetu N, Buchwald S, Mac Donald SG, Rand LI. Differential responsiveness to insulin of endothelial and support cells from micro and macrovessels. J Clin Invest 1983; 71: 974-9
• 23 Demovsek KD, Bar RS. Processing of cell bound insulin by capillary and macrovascular endothelial cells in culture. Am j Physiol 1985; 248: 244-51
• 24 Bar RS, Dolash S, Dake BL, Boes M. Cultured capillary endothelial cells from bovine adipose tissue: a model for insulin binding and action in microvascular endothelium. Metabolism 1986; 35: 317-22
• 25 Vinters HV, Berliner JA, Beck DW, Maxwell K, Bready JV, Cancilla PA. Insulin stimulates DNA synthesis in cerebral microvessel endothelium and smooth muscle. Diabetes 1985; 34: 964-9
• 26 Levin EG. Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells. Blood 1986; 67: 1309-13
• 27 Kooistra T, Sprengers ED, Van Hinsberg VW M. Rapid inactivation of the plasminogen activator upon secretion from cultured human endothelial cells. Biochem J 1986; 239: 497-503
• 28 Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979; 2: 131-41
• 29 Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2: 154-60
• 30 Ducimetiere D, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in middle-aged population. Diabetologia 1980; 19: 205-10